231 A SHORT TIME WINDOW TO PROFIT FROM IL-4 PLUS IL-10 ADDITION TO PROTECT CARTILAGE FROM BLOOD-INDUCED DAMAGE IN VITRO  by van Meegeren, M.E. et al.
Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236 S113
0.9, respectively. The scores of cartilage damage in the BMP-M group
were less severe than PBS group. The histological severity of OA in BMP-M
group was signiﬁcantly lower than PBS and BMP-S group according to
the modiﬁed Mankin’s histological grading. Remarkable inﬂammation or
hyperplasia of synovium was not observed in any group.
Conclusions: Local administration of therapeutic agents to joints is
reasonable in OA which is not systemic disease. The osmotic pumps
were previously used for the maintenance of effective concentration of
therapeutic agents in the joint of animal experiments. Biodegradable
GHM was reported to achieve controlled release of growth factors in the
condition that maintained the biological activity of growth factors. The
present study showed this sustained releasing system of BMP-7 in the
joint had protective effects on OA development in an animal model. This
method might be a useful conservative treatment for human OA in the
future.
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Fig. 1. In vivo release kinematics of BMP-7.
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Fig. 2. Gross morphological evaluation (score).
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A SHORT TIME WINDOW TO PROFIT FROM IL-4 PLUS IL-10 ADDITION
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Purpose: Exposure of joint cartilage to blood can occur after joint trauma,
during or after major joint surgery, or due to hemophilia. This ultimately
leads to joint damage, having both the inﬂammatory characteristics
of rheumatoid arthritis and the degenerative characteristics of
osteoarthritis. It has been reported that interleukin (IL)-10 limits blood-
induced cartilage damage in vitro and that IL-4 has some cartilage
protective properties. Our aim was to study whether the combination
of IL-4 and IL-10 has an additive effect on prevention of blood-induced
cartilage damage when administered during (prevention) and after the
onset (treatment) of blood-exposure.
Methods: Human full thickness articular cartilage explants were cultured
for 4 days in the presence or absence of 50% v/v homologous blood,
mimicking a joint bleed. Either IL-4 or IL-10 alone was added (0, 10,
30, or 100ng/ml) during blood exposure (n =9 donors). Additionally,
a combination of IL-4 and IL-10 was added during blood exposure
(prevention), as well as 2, 4, 8, 24, or 48 hours after start of blood-
exposure (treatment) (n = 5 donors). After 4 days of culture the medium
was refreshed and cartilage was cultured for an additional 12 days in
the absence of additives to determine long-term effects of short-term
blood-exposure and treatment. This mimics the in vivo situation where
blood is cleared from a joint within approximately 4 days and where
IL-4 and IL-10 have short half live times. Cartilage matrix turnover, in
terms of proteoglycan synthesis, -release, and -content, was determined
at day 16.
Results: Cartilage cultured in the presence of blood decreased
proteoglycan synthesis rate, increased proteoglycan release, and
decreased proteoglycan content as measured after 16 days of culture (all
p < 0.05). This blood-induced damage to the cartilage matrix was limited
both by IL-10 and IL-4 alone in a dose-dependent way. At 10ng/ml,
IL-10 and IL-4 improved proteoglycan synthesis rate with 41% and 125%,
respectively; proteoglycan release decreased with 42% and 59%, and
proteoglycan content increased both with 19% (all p< 0.05 compared to
blood-exposure).
Most importantly, the combination of IL-4 and IL-10 (10ng/ml) was
more protective against damage caused by blood than IL-10 alone. The
decrease of proteoglycan synthesis rate due to exposure to blood was
further improved with 157%, and proteoglycan release decreased with
59% (both p < 0.05 compared to IL-10 alone).
When IL-4 plus IL-10 were added after the onset of blood-exposure, it
appeared that it had to be administered within 8 hours after start of
the bleeding to still be able to protect against blood-induced cartilage
damage. At later time points addition was ineffective.
Conclusions: Besides IL-10, as shown previously, also IL-4 protects
against blood-induced cartilage damage. This study demonstrates that
the combination of IL-4 and IL-10 is clearly more effective than the
individual components. Importantly, the protective effect is only evident
when IL-4 and Il-10 are added within 8 hours after start of blood-
exposure. This implies that treatment should be started within this time
span to prevent blood-induced cartilage damage as a result of trauma or
surgery.
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Purpose: Mesenchymal stem cells (MSCs) are a source of pluripotent
cells. They are able to self renew, differentiate into cells of mesoderm
lineage and modulate the immune response. Here we focus on
the immunomodulatory properties of MSCs for therapeutic use in
osteoarthritis. We studied the possibility to encapsulate MSCs in
alginate beads in order to achieve long-term immunomodulatory activity
of MSCs and to place them in the jointcavity. We evaluated the
expression of immunomodulatory factors by MSC upon stimulation
with inﬂammatory factors when encapsulated in alginate compared
to monolayer. Furthermore we studied the survival and differentiation
capacity of MSCs after long-term encapsulation in alginate.
Methods: Human bone marrow MSCs of two different donors were
encapsulated in 1.2% alginate or seeded in monolayer and after
preconditioning for 48 hours they were stimulated by cytokines
(50ng/mL IFNg, 50 ng/mL TNFa) for 24 hours. Each experiment was
performed in triplicate. We studied the gene expression of MSCs
compared to unstimulated control cultures. To evaluate the behavior
after long-term encapsulation the above experiment was repeated after
30 days of preculture in alginate. We also measured the amount of
DNA in a time course experiment and evaluated MSCs multi-lineage
differentiation capacities after 1 and 30 days of encapsulation in alginate
beads. Mixed model ANOVA was used to calculate statistical signiﬁcance.
A p-value <0.05 was considered statistically signiﬁcance.
Results: Stimulation with IFNg and TNFa increased the expression of
TNFa, IL1b, IL-6 (Fig1A), IDO (Fig1B) and COX2 in MSCs, whereas VEGF
was downregulated (p < 0.05). TGFb1 and TIMP2 didn’t reach signiﬁcance
but showed a trend toward downregulation after cytokine treatment.
The response of MSCs in alginate was similar to MSCs in monolayer
culture. After 30 days in alginate the amount of DNA/alginate bead was
unchanged, suggesting MSCs survive but do not proliferate in alginate.
The cells still responded to inﬂammatory cytokines by increasing the
expression of TNFa, IL1b, IL-6 (Fig1A), IDO (Fig 1B) and COX2 and
